Pompeyo Viciana-Fernández1, Vicenç Falcó2, Manuel Castaño3, Ignacio de los Santos-Gil4, Julián Olalla-Sierra5, Asunción Hernando6, Elisabet Deig7, Bonaventura Clotet8, Hernando Knobel9, Daniel Podzamczer10, Pere Domingo Pedrol11. 1. Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen del Rocío, Sevilla, España. 2. Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebrón, Barcelona, España. 3. Servicio de Enfermedades Infecciosas, Hospital Regional Carlos Haya, Málaga, España. 4. Unidad de Enfermedades Infecciosas, Hospital Universitario de la Princesa, Madrid, España. 5. Unidad de Medicina Interna, Hospital Costa del Sol, Marbella, España. 6. Unidad de VIH, Hospital Universitario 12 de Octubre, Universidad Europea de Madrid, Madrid, España. 7. Unidad de VIH-Servicio de Medicina Interna, Hospital General de Granollers, Granollers, España. 8. Fundación IrsiCaixa, Instituto Germans Trias i Pujol, Barcelona, España. 9. Servicio de Enfermedades Infecciosas, Hospital del Mar, Barcelona, España. 10. Unidad VIH, Servicio de Enfermedades Infecciosas, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, España. 11. Unidad de Enfermedades Infecciosas, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: Pere.Domingo@uab.es.
Abstract
INTRODUCTION: In Spain, HIV treatment guidelines are well known and generally followed. However, in some patients there are no plans to initiate ART despite having treatment indications. The current barriers to ART initiation are presented. METHODS: A cross-sectional survey including every HIV infected patient in care in 19 hospitals across Spain in 2012, with ≥1 indication to start ART according to 2011 national treatment guidelines, who had not been scheduled for ART initiation. Reasons for deferring treatment were categorized as follows (non-exclusive categories): a) The physician thinks the indication is not absolute and prefers to defer it; b) The patient does not want to start it; c) The physician thinks ART must be started, but there is some limitation to starting it, and d) The patient has undetectable viral load in absence of ART. RESULTS: A total of 256 patients, out of 784 originally planned, were included. The large majority (84%) were male, median age 39 years, 57% MSM, 24% heterosexuals, and 16% IDUs. Median time since HIV diagnosis was 3 years, median CD4 count, 501 cells/mm3, median viral load 4.4 log copies/ml. Main ART indications were: CD4 count <500 cells/mm(3), 48%; having an uninfected sexual partner, 28%, and hepatitis C coinfection, 23%. Barriers due to, the physician, 55%; the patient, 28%; other limitations, 23%; and undetectable viral load, 6%. CONCLUSIONS: The majority of subjects with ART indication were on it. The most frequent barriers among those who did not receive it were physician-related, suggesting that the relevance of the conditions that indicate ART may need reinforcing.
INTRODUCTION: In Spain, HIV treatment guidelines are well known and generally followed. However, in some patients there are no plans to initiate ART despite having treatment indications. The current barriers to ART initiation are presented. METHODS: A cross-sectional survey including every HIV infectedpatient in care in 19 hospitals across Spain in 2012, with ≥1 indication to start ART according to 2011 national treatment guidelines, who had not been scheduled for ART initiation. Reasons for deferring treatment were categorized as follows (non-exclusive categories): a) The physician thinks the indication is not absolute and prefers to defer it; b) The patient does not want to start it; c) The physician thinks ART must be started, but there is some limitation to starting it, and d) The patient has undetectable viral load in absence of ART. RESULTS: A total of 256 patients, out of 784 originally planned, were included. The large majority (84%) were male, median age 39 years, 57% MSM, 24% heterosexuals, and 16% IDUs. Median time since HIV diagnosis was 3 years, median CD4 count, 501 cells/mm3, median viral load 4.4 log copies/ml. Main ART indications were: CD4 count <500 cells/mm(3), 48%; having an uninfected sexual partner, 28%, and hepatitis C coinfection, 23%. Barriers due to, the physician, 55%; the patient, 28%; other limitations, 23%; and undetectable viral load, 6%. CONCLUSIONS: The majority of subjects with ART indication were on it. The most frequent barriers among those who did not receive it were physician-related, suggesting that the relevance of the conditions that indicate ART may need reinforcing.
Keywords:
Antiretroviral treatment; Barreras al inicio del tratamiento; España; Human immunodeficiency virus; Spain; Tratamiento antirretroviral; Treatment barriers; Virus de la inmunodeficiencia humana
Authors: Vicente Estrada; Miguel Górgolas; José A Peña; Elena Tortajada; Antonio Castro; María Presa; Itziar Oyagüez Journal: Pharmacoecon Open Date: 2022-02-05